Caplin Point receives EIR for its sterile injectable plant at Gummidipoondi, TN

On successful inspection by USFDA

Caplin Point has received the Establishment Inspection Report from USFDA for the inspection carried out during 21 October - 27 October, 2016 at its sterile injectable plant at Gummidipoondi, Tamil Nadu.

The facility, capable of manufacturing liquid injectables in vials, ampoules, lyophilized vials and ophthalmic dosages, is approved by EU-GMP and ANVISA-Brasil.

Powered by Capital Market - Live News